Remyelination strategies: new advancements toward a regenerative treatment in multiple sclerosis.

Current Neurology and Neuroscience Reports
M Stangel, Corinna Trebst

Abstract

Spontaneous remyelination and repair mechanisms in multiple sclerosis are mostly insufficient and contribute to clinical disability. Treatments improving these processes are not yet available but basic research in animal models has led to the proposal of several repair strategies. These include enhancement of the naturally occurring mechanisms, remyelination due to a change of the immune response, and transfer of myelinating cells. Despite the encouraging experimental findings and the constantly increasing knowledge of the molecular mechanisms of remyelination and remyelination failure, there remain many questions before this knowledge can be successfully translated into clinical trials.

References

Jan 1, 1990·Annals of Neurology·M Rodriguez, V A Lennon
Jun 7, 1974·Nature·W F Blakemore
Jun 1, 1981·Brain : a Journal of Neurology·K J SmithW I McDonald
Feb 4, 1998·Molecular Medicine Today·I D DuncanS C Zhang
Sep 29, 1999·Journal of Neuroscience Research·R J Franklin, G L Hinks
Dec 3, 1999·Brain : a Journal of Neurology·C LucchinettiH Lassmann
Jun 7, 2000·Proceedings of the National Academy of Sciences of the United States of America·P CharlesC Lubetzki
Mar 29, 2001·Physiological Reviews·N Baumann, D Pham-Dinh
May 18, 2001·Brain Research. Developmental Brain Research·D Nguyen, M Stangel
Jan 11, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·M Stangel, H-P Hartung
Jan 18, 2002·The New England Journal of Medicine·Ansi ChangBruce D Trapp
Apr 9, 2002·Multiple Sclerosis : Clinical and Laboratory Research·J A FrankT Leist
Aug 17, 2002·Brain : a Journal of Neurology·Perrine CharlesCatherine Lubetzki
Oct 16, 2002·Nature Cell Biology·Holly ColognatoCharles ffrench-Constant
Jan 18, 2003·Progress in Neurobiology·Martin Stangel, Hans-Peter Hartung
Jan 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Eva MezeyBarbara Crain
May 6, 2003·Annals of Neurology·Allan J BieberMoses Rodriguez
Dec 6, 2003·Brain Pathology·Bogoljub CiricLarry R Pease
Mar 27, 2004·Science·Galin V MichailovKlaus-Armin Nave
Apr 16, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Laurence Decker, Charles ffrench-Constant
Apr 23, 2004·Expert Opinion on Investigational Drugs·Martin Stangel
May 14, 2004·Neurochemical Research·Maura Bozzali, Lawrence Wrabetz
Nov 24, 2004·Metabolic Brain Disease·Hannelore EhrenreichAnna-Leena Sirén
Feb 9, 2005·Experimental Neurology·Arthur M Butt, Jennifer Dinsdale
Feb 9, 2005·Brain : a Journal of Neurology·A K Foote, W F Blakemore
Feb 11, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Mei XinQ Richard Lu
Feb 11, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·C JaillardC Lubetzki
Mar 19, 2005·Brain : a Journal of Neurology·Kakuri M OmariCedric S Raine
May 4, 2005·Trends in Immunology·Zoë JohnsonAmanda E I Proudfoot
May 17, 2005·Nature Neuroscience·Sha MiR Blake Pepinsky

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.